JAMES JUNG: Open Payments
NPI 1912403460 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 16 payments from 8 companies in 2025. Trend: 2023 $1,559 · 2024 $359 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $245 |
| Sage Therapeutics, LLC | 2 | $51 |
| Tris Pharma Inc | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| bioMerieux Inc | 1 | $20 |
Products named: SPRAVATO, ZURZUVAE, Dyanavel XR, Auvelity, REXULTI, TRINTELLIX, VRAYLAR.
Industry payments across CA — which companies pay providers there.
